A phase I study of docetaxel/oxaliplatin/S-1 (DOS) combination neoadjuvant chemotherapy for patients with locally advanced adenocarcinoma of the esophagogastric junction
about
A phase I study of docetaxel/oxaliplatin/S-1 (DOS) combination neoadjuvant chemotherapy for patients with locally advanced adenocarcinoma of the esophagogastric junction
description
2020 nî lūn-bûn
@nan
2020年の論文
@ja
2020年学术文章
@wuu
2020年学术文章
@zh
2020年学术文章
@zh-cn
2020年学术文章
@zh-hans
2020年学术文章
@zh-my
2020年学术文章
@zh-sg
2020年學術文章
@yue
2020年學術文章
@zh-hant
name
A phase I study of docetaxel/o ...... f the esophagogastric junction
@en
type
label
A phase I study of docetaxel/o ...... f the esophagogastric junction
@en
prefLabel
A phase I study of docetaxel/o ...... f the esophagogastric junction
@en
P2093
P1476
A phase I study of docetaxel/o ...... f the esophagogastric junction
@en
P2093
Akinori Watanabe
Chikatoshi Katada
Hideki Ushiku
Hiroki Harada
Keishi Yamashita
Kenji Ishido
Marie Washio
Masahiro Niihara
Mikiko Sakuraya
Mizutomo Azuma
P356
10.1007/S10147-020-01638-5
P50
P577
2020-03-02T00:00:00Z